{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:09:35Z","timestamp":1794953375214,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s12325-023-02608-9","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T08:02:31Z","timestamp":1690358551000},"page":"4405-4420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":304,"title":["Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme"],"prefix":"10.1007","volume":"40","author":[{"given":"Vivekanand","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed M. G.","family":"Al-Ghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guisen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai-Szu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Stafylas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Retat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Card-Gowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6546-7769","authenticated-orcid":false,"given":"Juan Jose","family":"Garcia Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"issue":"7","key":"2608_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease\u2014a systematic review and meta-analysis. PLoS ONE. 2016;11(7): e0158765.","journal-title":"PLoS ONE"},{"issue":"1","key":"2608_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7\u201311.","journal-title":"Kidney Int Suppl"},{"key":"2608_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-13-8871-2_1","volume":"1165","author":"JC Lv","year":"2019","unstructured":"Lv JC, Zhang LX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol. 2019;1165:3\u201315.","journal-title":"Adv Exp Med Biol"},{"issue":"10225","key":"2608_CR4","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S0140-6736(19)32977-0","volume":"395","author":"P Cockwell","year":"2020","unstructured":"Cockwell P, Fisher L-A. The global burden of chronic kidney disease. Lancet. 2020;395(10225):662\u20134.","journal-title":"Lancet"},{"issue":"1","key":"2608_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2010.483","volume":"80","author":"AS Levey","year":"2011","unstructured":"Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80(1):17\u201328.","journal-title":"Kidney Int"},{"key":"2608_CR6","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;113:S1\u2013130."},{"issue":"693","key":"2608_CR7","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.3399\/bjgp20X708245","volume":"70","author":"JA Hirst","year":"2020","unstructured":"Hirst JA, Hill N, O\u2019Callaghan CA, et al. Prevalence of chronic kidney disease in the community using data from OxRen: a UK population-based cohort study. Br J Gen Pract. 2020;70(693):e285\u201393.","journal-title":"Br J Gen Pract"},{"issue":"4","key":"2608_CR8","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1016\/j.ekir.2021.03.316","volume":"6","author":"A Abdul Sultan","year":"2021","unstructured":"Abdul Sultan A, Wittbrodt E, Malvolti E, et al. POS-300 Patient-reported early stage chronic kidney disease. Kidney Int Rep. 2021;6(4):S129.","journal-title":"Kidney Int Rep."},{"issue":"3","key":"2608_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3109\/00365599.2011.649045","volume":"46","author":"SD Baek","year":"2012","unstructured":"Baek SD, Baek CH, Kim JS, et al. Does stage III chronic kidney disease always progress to end-stage renal disease? A ten-year follow-up study. Scand J Urol Nephrol. 2012;46(3):232\u20138.","journal-title":"Scand J Urol Nephrol"},{"key":"2608_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1477-7525-10-71","volume":"10","author":"AA Pagels","year":"2012","unstructured":"Pagels AA, S\u00f6derkvist BK, Medin C, et al. Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment. Health Qual Life Outcomes. 2012;10:71.","journal-title":"Health Qual Life Outcomes"},{"key":"2608_CR11","unstructured":"United States Renal Data System. Annual Data Report: Epidemiology of kidney disease in the United States. 2022 Available at: https:\/\/adr.usrds.org\/2022 [Accessed 01\/07\/2022]."},{"issue":"3","key":"2608_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230512","volume":"15","author":"S Elshahat","year":"2020","unstructured":"Elshahat S, Cockwell P, Maxwell AP, et al. The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review. PLoS ONE. 2020;15(3): e0230512.","journal-title":"PLoS ONE"},{"issue":"7","key":"2608_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrneph.2017.63","volume":"13","author":"R Vanholder","year":"2017","unstructured":"Vanholder R, Annemans L, Brown E, et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol. 2017;13(7):393\u2013409.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"2608_CR14","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s12325-020-01607-4","volume":"38","author":"O Darlington","year":"2021","unstructured":"Darlington O, Dickerson C, Evans M, et al. Costs and healthcare resource use associated with risk of cardiovascular morbidity in patients with chronic kidney disease: Evidence from a systematic literature review. Adv Ther. 2021;38(2):994\u20131010.","journal-title":"Adv Ther"},{"issue":"5","key":"2608_CR15","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","volume":"42","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003;42(5):1050\u201365.","journal-title":"Hypertension"},{"key":"2608_CR16","volume-title":"ISN\u2013Global Kidney Health Atlas: A report by the International Society of Nephrology: An Assessment of Global Kidney Health Care Status focussing on Capacity, Availability, Accessibility","author":"AK Bello","year":"2023","unstructured":"Bello AK, Okpechi IG, Levin A, et al. ISN\u2013Global Kidney Health Atlas: A report by the International Society of Nephrology: An Assessment of Global Kidney Health Care Status focussing on Capacity, Availability, Accessibility. Affordability and Outcomes of Kidney Disease: International Society of Nephrology; 2023."},{"issue":"1","key":"2608_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12325-022-02353-5","volume":"40","author":"N Tangri","year":"2023","unstructured":"Tangri N, Chadban S, Cabrera C, et al. Projecting the epidemiological and economic impact of chronic kidney disease using patient-level microsimulation modelling: Rationale and methods of Inside CKD. Adv Ther. 2023;40(1):265\u201381.","journal-title":"Adv Ther"},{"key":"2608_CR18","unstructured":"The World Bank. Domestic private health expenditure (% of current health expenditure). 2021. Available at: https:\/\/data.worldbank.org\/indicator\/SH.XPD.PVTD.CH.ZS [Accessed 01\/06\/2021]."},{"key":"2608_CR19","unstructured":"The World Bank. Current health expenditure per capita, PPP (current international $). 2021. Available at: https:\/\/data.worldbank.org\/indicator\/SH.XPD.CHEX.PP.CD [Accessed 01\/06\/2021]."},{"key":"2608_CR20","unstructured":"The World Bank. UHC service coverage index. 2021. Available at: https:\/\/data.worldbank.org\/indicator\/SH.UHC.SRVS.CV.XD [Accessed 01\/06\/2022]."},{"key":"2608_CR21","unstructured":"International Monetary Fund. World Economic Outlook Database. 2022. Available at: https:\/\/www.imf.org\/en\/Publications\/WEO\/weo-database\/2022\/October [Accessed 01\/11\/2022]."},{"key":"2608_CR22","unstructured":"International Monetary Fund. World Economic Outlook Report. 2022. Available at: https:\/\/www.imf.org\/en\/Publications\/WEO\/Issues\/2022\/10\/11\/world-economic-outlook-october-2022 [Accessed 27\/02\/2023]."},{"issue":"8","key":"2608_CR23","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.2337\/diacare.26.8.2300","volume":"26","author":"M Brandle","year":"2003","unstructured":"Brandle M, Zhou H, Smith BRK, et al. The direct medical cost of type 2 diabetes. Diabetes Care. 2003;26(8):2300\u20134.","journal-title":"Diabetes Care"},{"key":"2608_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2147\/COPD.S13771","volume":"5","author":"AA Dalal","year":"2010","unstructured":"Dalal AA, Christensen L, Liu F, et al. Direct costs of chronic obstructive pulmonary disease among managed care patients. Int J Chron Obstruct Pulmon Dis. 2010;5:341\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2608_CR25","unstructured":"World Economic Forum. Partnership for Health System Sustainability and Resilience. 2022. Available at: https:\/\/www.weforum.org\/phssr [Accessed 24\/03\/2022]."},{"issue":"9","key":"2608_CR26","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1681\/ASN.2012040392","volume":"24","author":"AA Honeycutt","year":"2013","unstructured":"Honeycutt AA, Segel JE, Zhuo X, et al. Medical costs of CKD in the medicare population. J Am Soc Nephrol. 2013;24(9):1478\u201383.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2608_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231375","volume":"15","author":"A Gandjour","year":"2020","unstructured":"Gandjour A, Armsen W, Wehmeyer W, et al. Costs of patients with chronic kidney disease in Germany. PLoS ONE. 2020;15(4): e0231375.","journal-title":"PLoS ONE"},{"issue":"12","key":"2608_CR28","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1080\/13696998.2020.1830782","volume":"23","author":"J Darb\u00e0","year":"2020","unstructured":"Darb\u00e0 J, Mars\u00e0 A. Chronic kidney disease in Spain: analysis of patient characteristics, incidence and direct medical costs (2011\u20132017). J Med Econ. 2020;23(12):1623\u20139.","journal-title":"J Med Econ"},{"issue":"4","key":"2608_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2022.100439","volume":"4","author":"SN Michalopoulos","year":"2022","unstructured":"Michalopoulos SN, Gauthier-Loiselle M, Aigbogun MS, et al. Patient and care partner burden in CKD patients with and without anemia: a US-based survey. Kidney Med. 2022;4(4): 100439.","journal-title":"Kidney Med"},{"issue":"1","key":"2608_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12882-021-02552-2","volume":"22","author":"L Kirkeskov","year":"2021","unstructured":"Kirkeskov L, Carlsen RK, Lund T, et al. Employment of patients with kidney failure treated with dialysis or kidney transplantation\u2014a systematic review and meta-analysis. BMC Nephrol. 2021;22(1):348.","journal-title":"BMC Nephrol"},{"key":"2608_CR31","unstructured":"United States Renal Data System. Annual Data Report: International Comparisons. 2022. Available at: https:\/\/usrds-adr.niddk.nih.gov\/2022\/end-stage-renal-disease\/11-international-comparisons. Accessed 16\/06\/2023."},{"issue":"1","key":"2608_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s41100-018-0186-3","volume":"4","author":"A Aikawa","year":"2018","unstructured":"Aikawa A. Current status and future aspects of kidney transplantation in Japan. Renal Replacement Ther. 2018;4(1):50.","journal-title":"Renal Replacement Ther"},{"issue":"6","key":"2608_CR33","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/TP.0000000000003943","volume":"106","author":"D Mudiayi","year":"2022","unstructured":"Mudiayi D, Shojai S, Okpechi I, et al. Global estimates of capacity for kidney transplantation in world countries and regions. Transplantation. 2022;106(6):1113\u201322.","journal-title":"Transplantation"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02608-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02608-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02608-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T01:12:30Z","timestamp":1694567550000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02608-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["2608"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02608-9","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,26]]},"assertion":[{"value":"30 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}